1. Home
  2. NNVC vs ACGLO Comparison

NNVC vs ACGLO Comparison

Compare NNVC & ACGLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

NNVC

NanoViricides Inc.

N/A

Current Price

$1.28

Market Cap

35.2M

Sector

Health Care

ML Signal

N/A

Logo Arch Capital Group Ltd. Depositary Shares Each Representing 1/1000th Interest in a Share of 5.45% Non-Cumulative Preferred Shares Series F

ACGLO

Arch Capital Group Ltd. Depositary Shares Each Representing 1/1000th Interest in a Share of 5.45% Non-Cumulative Preferred Shares Series F

N/A

Current Price

$18.39

Market Cap

0.0

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
NNVC
ACGLO
Founded
2005
N/A
Country
United States
Bermuda
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Property-Casualty Insurers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
35.2M
N/A
IPO Year
2008
1996

Fundamental Metrics

Financial Performance
Metric
NNVC
ACGLO
Price
$1.28
$18.39
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
★ $6.00
N/A
AVG Volume (30 Days)
★ 601.5K
39.2K
Earning Date
09-28-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
★ 34.92
3.66
EPS
N/A
★ 5.88
Revenue
N/A
★ $19,929,000,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
$3.15
Revenue Growth
N/A
★ 14.27
52 Week Low
$0.85
$18.06
52 Week High
$2.23
$22.06

Technical Indicators

Market Signals
Indicator
NNVC
ACGLO
Relative Strength Index (RSI) 46.97 35.76
Support Level $1.21 $18.06
Resistance Level $1.38 $19.21
Average True Range (ATR) 0.15 0.32
MACD 0.00 -0.02
Stochastic Oscillator 36.31 19.77

Price Performance

Historical Comparison
NNVC
ACGLO

About NNVC NanoViricides Inc.

Nanoviricides Inc is a nano-biopharmaceutical company that is engaged in discovering, developing, and commercializing therapeutics to advance the care of patients suffering from life-threatening viral infections. The company engaged in the application of nanomedicine technologies to the complex issues of viral diseases. It focuses its research and clinical programs on specific anti-viral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs and through in-licensing.

About ACGLO Arch Capital Group Ltd. Depositary Shares Each Representing 1/1000th Interest in a Share of 5.45% Non-Cumulative Preferred Shares Series F

Arch Capital Group Ltd is a Bermuda company that writes insurance and reinsurance with operations in the United States, Canada, Europe, Australia, and the United Kingdom. The business operates through three underwriting segments: insurance, reinsurance, and mortgage. The insurance segment provides specialty risk solutions to clients across various industries. The reinsurance segment provides reinsurance services which cover property catastrophe, property, liability, marine, aviation and space, trade credit and surety, agriculture, accident, life and health, and political risk. The mortgage business provides risk management and risk financing products to the mortgage insurance sectors through platforms in the U.S., Europe and Bermuda.

Share on Social Networks: